Artera AI News and Activities

View the org chart displaying its 13 main executives

Most searched biographies at Artera AI

• Andre Esteva, Director and Chief Executive Officer
• Catherine Spina, Director
• George Rehm, Director

Popular executive movements at Artera AI

• Erin Stewart, Vice President of Clinical Development, has left the company  (posted on April 23 2026).
• Tammi Yee, Head of People Operations, has left the company  (posted on April 23 2026).

Create your alert
to follow the executive moves at Artera AI.

Artera AI has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Artera AI

• Optimizing Kubernetes Log Aggregation: Tackling Fluent Bit Buffering and Backpressure Challenges
• AI significantly improves risk classification for prostate cancer metastasis
• Artera’s Multimodal Artificial Intelligence Named Among TIME's 2024 Best Inventions
• Artera Receives California Lab License, Expanding Access to its ArteraAI Prostate Test
• MedCity Pivot Podcast: How AI Can Help in Cancer - MedCity News
• Artera Announces Two Presentations at ASTRO 2024 Validating its MMAI Platform to Inform Treatment Decisions for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC)
• Artera Product Webinar - August
• Artera Announces Three Presentations at ASCO 2024 That Demonstrate the Reliability and Depth of its AI Cancer Platform
• ArteraAI and Movember Announce New Relationship
• ArteraAI Announced as the First-and-Only Predictive Test for Therapy Personalization in the 2024 NCCN Guidelines® for Prostate Cancer
• View more press releases Close

Social media about Artera AI

• Artera AI on Wikipedia, Google News & Yahoo Finance
• Artera AI on LinkedIn, X (Twitter) & YouTube